In this section, you can review the key results from the pivotal clinical trials for approved anti-integrin therapies in ulcerative colitis and Crohn’s disease.
Discover an overview of the relevant anti-integrin clinical trial data for ulcerative colitis.
Review the key results from the GEMINI 2, GEMINI 3, and GEMINI LTS trials in Crohn’s disease.
Alternatively login via
Anticoagulation Therapy for Stroke Prevention
ESICM LIVES Highlights
Chronic Lymphocytic Leukaemia (CLL)
Back to epgonline.org